Treatment of patients with hematologic neoplasm, fever, and neutropenia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15768331.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Choices of empirical antibiotic therapy for patients with febrile neutropenia must be made with very little information about the source and site of infection. The clinician is aided by recognition of the subtle signs and symptoms of infection in immunocompromised patients. National guidelines should be applied according to the microbiological patterns and trends in drug resistance at each institution. Case studies are provided to illustrate these challenges in daily practice.
Medical subject headings
- Anti-Bacterial Agents
- Hematologic Neoplasms
- Immunocompromised Host
- Neutropenia
- Opportunistic Infections